Psychedelic Insiders

On this episode of Psychedelic Insiders, Doug Drysdale, CEO of Cybin Inc. powers through a cold to share some insights on the present and future of psychedelic medicine. He talks to Microdose's Jason Najum about psychedelic drug development, mental health therapies involving psychedelics, and more.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

LINKS:

Video of interview: https://youtu.be/7AfG58q-KGw

www.cybin.com

www.microdose.buzz

Subscribe today!

on Apple Podcasts: https://podcasts.apple.com/us/podcast/psychedelic-insiders/id1531628901

on Spotify: https://open.spotify.com/show/3Nyc58Ov7GYBeeLcWheBSx

on Youtube: https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1

On this episode of Psychedelic Insiders, Jeeshan Chowdhury, Co-Founder and CEO of Journey CoLab opens up about his intentional path set for the company, using mescaline as medicine to combat endemic addictions like Alcohol Use Disorder. He talks to Jason Najum about drug development, psychedelic mental health care, and more.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

LINKS:

Video of interview: https://youtu.be/qq2wCyJ3aCc

www.journeycolab.com

www.microdose.buzz

Subscribe today!

on Apple Podcasts: https://podcasts.apple.com/us/podcast/psychedelic-insiders/id1531628901

on Spotify: https://open.spotify.com/show/3Nyc58Ov7GYBeeLcWheBSx

on Youtube: https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1

On this episode of Psychedelic Insiders, Najla Guthrie, CEO of KGK Science opens up about her 25 years experience in straightening out the wild field of natural medicines. She talks to Jason Najum about her business experience, how to go about drug development the right way, various regulatory bodies, and more.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

LINKS:

Video of interview: https://youtu.be/XJL1FKmi4JI

www.kgkscience.com

www.microdose.buzz

Janet talks about her mission to pursue breakthrough medicines via her company PurMinds Biopharma. She talks to Jason Najum about her business experience, ALS, data science, drug development, neuroscience, the FDA, and more.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

LINKS:

www.purminds.com

www.microdose.buzz

Subscribe to the Playlist:

https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1

Hashtags: #PurMinds #FemaleCEO #BioPharma #JanetQi #MentalHealth #ALS #Psychedelics #Psychedelia #Health #Medicine #Healing #Pharmaceuticals #DrugDevelopment #ClinicalTrials

“Everyday is psychedelic”, that’s the motto of Psychedelic Water, the world’s first legal psychedelic beverage.Microdose writer Jason Najum sat down with Psychedelic Water CEO Pankaj Gojia to discuss the company's mission and product.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

LINKS:

VIDEO VERSION: https://youtu.be/kQA-Oemyy-Q

www.psychedelicwater.com

www.microdose.buzz

Robin Arnott has been studying ways of invoking psychedelic experiences through technology. Jason Najum goes deep into the nebulous realm of possible human experiences.

Watch the live video interview at: https://youtu.be/p_coZ3pZ-wQ

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

https://my.captivate.fm/www.microdose.buzz (www.microdose.buzz)

Matthew Johnson, graced by the psychedelic Gods with regulatory approval and grants from the US Federal government, has been studying psychedelics with fervour as they are his pharmacological passion. Jason Najum of Microdose Psychedelic Insights takes us on a wild ride of an interview that may or may not end in Jason's microdose turning him into a cat.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

https://my.captivate.fm/www.microdose.buzz (www.microdose.buzz)

Matthew JohnsonSusan Hill Ward Professor of Psychedelics and Consciousness

Johns Hopkins University School of Medicine

Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins University School of Medicine. Working with psychedelics since 2004, he is one of the world’s most widely published experts on psychedelics. He has published over 150 scientific papers, including psychedelic safety guidelines (2008) that helped to resurrect human psychedelic research, first research on psychedelic treatment of tobacco addiction (2014), and studies of psilocybin in cancer-related distress (2016) and depression (2020). His psilocybin review recommended Schedule IV upon potential medical approval (2018). Matt also conducts behavioral economic research on the psychology of addiction and sexual risk. He is a past President of the Psychopharmacology and Substance Abuse Division of the American Psychological Association, and current President of the International Society for Research on Psychedelics. In 2021 Matt received as principal investigator the first grant awarded by the US government in 50 years for a treatment trial of a classic psychedelic (psilocybin for smoking cessation). He has been interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, the BBC, CNN, Fox Business News, NPR, and in Michael Pollan’s book How to Change Your Mind.

Twitter: @Drug_Researcher

In support of fellow advocates and entrepreneurs in the psychedelic medicine space, Mircrodose sat down with the team behind the "Psychedelic Frontiers Virtual Summit".

The virtual conference is taking place this weekend and will feature interviews with over 40 leading experts in the field. The event is free to attend.

Check it out at: https://www.psychedelicfrontiers.ca/ (www.psychedelicfrontiers.ca)

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

www.microdose.buzz

Microdose's Jason Najum sat down with Field Trip founder Ronan Levy to discuss the NASDAQ, new molecules, and how to bring magic and poetry to the business world.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Ronan Levy, Executive Chairman and Co-Founder, Field Trip Health

Co-founder of Field Trip Psychedelics, a partner at Grassfed Ventures, a venture capital and advisory firm focused on the cannabis and biotech industries and a director for Trait Biosciences Inc.

www.microdose.buzz

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

Nicholas Kadysh, PharmAla Biotech, Psyched WellnessNick Kadysh spent the majority of his career helping companies navigate complex regulatory risk in Healthcare. After a career in Government at the Federal and Provincial levels, he has served as Head of Corporate Affairs at JUUL Labs Canada, Government Affairs and Public Leader at GE Healthcare and Director of Public Affairs for Red Bull Canada. Nick is the Founder of PharmAla Biotech, dedicated to the manufacture of MDMA and MDXX class molecules for pharmaceutical research.

www.microdose.buzzWatch this Podcast on Youtube: https://youtu.be/CgFqvnRLN6U